Association of lung function with cognitive decline and dementia: The Atherosclerosis Risk in Communities (ARIC) Study

European Journal of Neurology

Volumn 18, Issue 6, 2011, Pages 888-898

  Pathan, S S ^a   Gottesman, R F ^b   Mosley, T H ^c   Knopman, D S ^d   Sharrett, A R ^e   Alonso, A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cognitive decline; Dementia; Lung function; Prospective studies

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; DEMENTIA; FEMALE; FLUENCY DISORDER; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENOTYPE; GROUPS BY AGE; HAZARD RATIO; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; WORD RECOGNITION;

AFRICAN AMERICANS; AGED; ATHEROSCLEROSIS; COGNITION DISORDERS; COHORT STUDIES; COMORBIDITY; DEMENTIA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RISK REDUCTION BEHAVIOR; VITAL CAPACITY;

EID: 79955742853     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03340.x     Document Type: Article

References (40)

1. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology 2007; 68: 326-337.
2. Borenstein Graves A. Alzheimer's disease and vascular dementia. In: Nelson LM, Tanner CM, Van Den Eeden SK, McGuire V eds. Neuroepidemiology: From Principles to Practice. New York: Oxford University Press, 2004: 102-130.
3. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-48.
4. Alonso A, Mosley TH, Gottesman R, Catellier D, Sharrett AR, Coresh J. Risk of dementia hospitalization associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) Study. J Neurol Neurosurg Psychiatr 2009; 80: 1194-1201.
5. Albert MS, Jones K, Savage CR, et al. Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging 1995; 10: 578-589.
6. Emery CF, Pedersen NL, Svartengren M, McClearn GE. Longitudinal and genetic effects in the relationship between pulmonary function and cognitive performance. J Gerontol B Psychol Sci Soc Sci 1998; 53: P311-P317.
7. Chyou P-H, White LR, Yano K, et al. Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol 1996; 143: 750-756.
8. Richards M, Strachan D, Hardy R, Kuh D, Wadsworth M. Lung function and cognitive ability in a longitudinal birth cohort study. Psychosom Med 2005; 67: 602-608.
9. Guo X, Waern M, Sjogren K, et al. Midlife respiratory function and incidence of Alzheimer's disease: a 29-year longitudinal study in women. Neurobiol Aging 2007; 28: 343-350.
10. Giltay EJ, Nissinen A, Giampaoli S, Kromhout D. Apolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age. Dement Geriatr Cogn Disord 2009; 28: 433-441.
11. Alonso A, Jacobs DR Jr, Menotti A, et al. Cardiovascular risk factors and dementia mortality: 40years of follow-up in the Seven Countries Study. J Neurol Sci 2009; 280: 79-83.
12. Peers C, Dallas ML, Boycott HE, Scragg JL, Pearson HA, Boyle JP. Hypoxia and neurodegeneration. Ann N Y Acad Sci 2009; 1177: 169-177.
13. Engstrom G, Lind P, Hedblad B, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106: 2555-2560.
14. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 2010; 35: 913-922.
15. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 1989; 129: 687-702.
16. The ARIC investigators. Atherosclerosis Risk in Communities Study Manual 4: Pulmonary Function. Chapel Hill, NC: National Heart, Lung, and Blood Institute of the National Institutes of Health, Collaborative Studies Coordinating Center, University of North Carolina, 1987.
17. Cerhan JR, Folsom AR, Mortimer JA, et al. Correlates of cognitive function in middle-aged adults. Gerontology 1998; 44: 95-105.
18. Knopman DS, Ryberg S. A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Arch Neurol 1989; 46: 141-145.
19. Wechsler D. The Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corp., 1981.
20. Lezak MD. Neuropsychological Assessment, 3rd edn. New York: Oxford University Press, 1995.
21. Baecke JAH, Burema J, Fritjers JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-942.
22. The ARIC investigators. Atherosclerosis Risk in Communities Study Manual 7: Blood Collection. Chapel Hill, NC: National Heart, Lung, and Blood Institute of the National Institutes of Health, Collaborative Studies Coordinating Center, University of North Carolina, 1987.
23. McGowan L, Dickens C, Percival C, Douglas J, Tomenson B, Creed F. The relationship between vital exhaustion, depression and comorbid illnesses in patients following first myocardial infarction. J Psychosom Res 2004; 57: 183-188.
24. Appels A, Höppener P, Mulder P. A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol 1987; 17: 15-24.
25. Volcik KA, Barkley RA, Hutchinson RG, et al. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12, 491 ARIC Study participants. Am J Epidemiol 2006; 164: 342-348.
26. Scarlata S, Pedone C, Fimognari FL, Bellia V, Forastiere F, Incalzi RA. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. Respir Med 2008; 102: 1349-1354.
27. Zhang X, Loberiza FR, Klein JP, Zhang M-J. A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. Comput Methods Programs Biomed 2007; 88: 95-101.
28. van Dijk EJ, Vermeer SE, de Groot JC, et al. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatr 2004; 75: 733-736.
29. Guo X, Pantoni L, Simoni M, et al. Midlife respiratory function related to white matter lesions and lacunar infarcts in late life. The Prospective Population Study of Women in Gothenburg, Sweden. Stroke 2006; 37: 1658-1662.
30. Yeh H-C, Punjabi NM, Wang N-Y, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 1472-1479.
31. Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003; 158: 1171-1181.
32. Schroeder EB, Welch VL, Evans GW, Heiss G. Impaired lung function and subclinical atherosclerosis: the ARIC study. Atherosclerosis 2005; 180: 367-373.
33. Newman AB, Fitzpatrick AL, Lopez O, et al. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study Cohort. J Am Geriatr Soc 2005; 53: 1101-1107.
34. Jiang R, Burke GL, Enright PL, et al. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol 2008; 168: 602-610.
35. Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann Neurol 2002; 52: 168-174.
36. Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal analysis. Thorax 2010; 65: 499-504.
37. Wannamethee SG, Shaper AG, Rumley A, et al. Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation. Diabetes Care 2010; 33: 1990-1996.
38. Hernán MA, Alonso A, Logroscino G. Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology 2008; 19: 448-450.
39. Bretsky PM, Buckwalter JG, Seeman TE, et al. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 1999; 13: 216-221.
40. Bartrés-Faz D, Junqué C, Moral P, López-Alomar A, Sánchez-Aldeguer J, Clemente IC. Apolipoprotein E gender effects on cognitive performance in age-associated memory impairment. J Neuropsychiatry Clin Neurosci 2002; 14: 80-83.